News
Axoft, a neurotechnology company, today announced preliminary results from its first-in-human clinical study, FINESSE, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results